dipyridamole has been researched along with methotrexate in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (34.55) | 18.7374 |
1990's | 13 (23.64) | 18.2507 |
2000's | 13 (23.64) | 29.6817 |
2010's | 10 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
Bindels, RJM; Peters, JGP; Russel, FGM; Smeets, PHE; van Aubel, RAMH | 1 |
Hummel-Eisenbeiss, J; Jedlitschky, G; Keppler, D; Nies, AT; Rius, M | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bankala, R; Doss, HM; Kapavarapu, RK; Kulkarni, P; Kumar, JS; Mathew, JE; Medishetti, R; Mudgal, J; Pal, M; Parsa, KVL; Ramarao, EVVS; Rasool, M; Shenoy, GG; Sunke, R; Thirupataiah, B | 1 |
Marz, R; Plagemann, PG; Wohlhueter, RM | 1 |
Grem, JL | 1 |
Taniki, T; Weber, G; Zhen, YS | 1 |
Harstrick, A; Köhne-Wömpner, CH; Poliwoda, H; Schmoll, HJ; Schöber, C; Wilke, H | 1 |
Chan, TC; Howell, SB | 1 |
Donaldson, JT; Keane, TE; Norwood, DL; Poulton, SH; Rosner, G; Walther, PJ | 1 |
Clarke, R; Kennedy, DG; Murphy, RF; Van den Berg, HW | 1 |
Milstone, LM; Schwartz, PM | 1 |
Goel, R; Howell, SB; Kirmani, S | 1 |
Lönn, S; Lönn, U; Nylen, U; Winblad, G | 1 |
Cao, SS | 1 |
Bennett, A; Chambers, EA; Gaffen, JD | 1 |
Goel, R; Howell, SB; Sanga, R | 1 |
Higano, CS; Livingston, RB | 1 |
Cao, SS; Zhen, YS | 1 |
Balis, FM; Cleary, SM; Goel, R; Horton, C; Howell, SB; Kirmani, S; Zimm, S | 1 |
Alberti, D; Bruggink, J; Fischer, PH; Grem, JL; Nieting, L; Remick, SC; Trump, DL; Tutsch, KD; Willson, JK | 1 |
Hughes, JM; Tattersall, MH | 1 |
Fischer, PH; Pangallo, CA; Van Mouwerik, TJ; Willson, JK | 1 |
Green, MD; Muggia, FM; Subar, M; Wadler, S; Wiernik, PH | 1 |
Mroczka, D; Nelson, JA | 1 |
Plagemann, PG; Wohlhueter, RM | 1 |
Drake, S; Nelson, JA | 1 |
Bover, L; Cabral, S; Leis, S; Mordoh, J; Nembrot, M | 1 |
Bermúdez, J; Roig, T | 1 |
Goz, B; Jeffs, L | 1 |
Alcaraz, JE; Heath, DD; Howell, SB; Jekunen, AP; Shalinsky, DR | 1 |
Hirose, M; Kuroda, Y; Takeda, E | 1 |
Bamberger, U; Boven, E; Feller, N; Jansen, WJ; Pinedo, HM; van der Wilt, CL | 1 |
Anderson, M; Chu, E; Dearing, MP; Englee-Miller, MJ; Gazdar, AF; Kramer, BS; Kratzke, RA; Mulshine, JL; Venzon, D; Weinstein, J | 1 |
Köhne, CH; Schmoll, HJ; Schöffski, P; Wilke, H | 1 |
Büchele, T; Dempke, W; Grothey, A; Schmoll, HJ | 1 |
McIvor, RS; Sweeney, CL; Warlick, CA | 1 |
Dzhandzhugazyan, KN; Guldberg, P; Kirkin, AF; Worm, J | 1 |
Cole, PD; Kamen, BA; Smith, AK | 1 |
Barrera, P; Riksen, NP; Rongen, GA; Smits, P; van den Broek, PH; van Riel, PL | 1 |
Corzo, C; de Anta, JM; Espinet, B; Mayo, C; Mayol, X; Petzold, M; Real, FX; Salido, M; Serrano, S; Solé, F; Villa, O | 1 |
Ahishali, E; Akyuz, F; Badur, S; Demir, K; Gurel Polat, N; Ibrisim, D; Kaymakoglu, S; Mungan, Z; Poturoglu, S | 1 |
Bartier, WA; Chong, L; Ma, G; Tattersall, MH | 1 |
Hyland, KA; McIvor, RS; Olson, ER | 1 |
5 review(s) available for dipyridamole and methotrexate
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Biochemical modulation of fluorouracil by dipyridamole: preclinical and clinical experience.
Topics: Colonic Neoplasms; Deoxyuridine; Dipyridamole; DNA Damage; DNA, Neoplasm; Drug Interactions; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Methotrexate; Nucleosides; Nucleotides; RNA, Neoplasm; Thymidine; Tumor Cells, Cultured; Uridine Monophosphate | 1992 |
Modulation of cytotoxic drug activity by dipyridamole.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Cytarabine; Dipyridamole; Drug Interactions; Etoposide; Fluorouracil; Humans; Leucovorin; Methotrexate | 1990 |
The dead end of 5-fluorouracil double modulation and promise of continuous infusion schedules in the treatment of metastatic colorectal cancer.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Aspartate Carbamoyltransferase; Aspartic Acid; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Combined Modality Therapy; Dipyridamole; Drug Administration Schedule; Drug Synergism; Enzyme Inhibitors; Female; Fluorouracil; Humans; Immunologic Factors; Infusions, Intravenous; Injections, Intravenous; Interferons; Leucovorin; Liver Neoplasms; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Proteins; Nucleotides; Palliative Care; Phosphonoacetic Acid; Randomized Controlled Trials as Topic; Thymidylate Synthase | 1996 |
Where do we stand with 5-fluorouracil?
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Chronotherapy; Colorectal Neoplasms; Dipyridamole; Drug Synergism; Fluorouracil; Humans; Interferons; Leucovorin; Levamisole; Methotrexate; Phosphonoacetic Acid; Radiation-Sensitizing Agents; Trimetrexate; Zidovudine | 1999 |
1 trial(s) available for dipyridamole and methotrexate
Article | Year |
---|---|
Oral dipyridamole and methotrexate in human solid tumors: a toxicity trial.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Dipyridamole; Dose-Response Relationship, Drug; Drug Synergism; Humans; Injections, Intramuscular; Injections, Intravenous; Methotrexate; Neoplasms; Time Factors | 1989 |
49 other study(ies) available for dipyridamole and methotrexate
Article | Year |
---|---|
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP.
Topics: Adenosine Triphosphate; Animals; Cell Line; Cell Membrane; Cyclic AMP; Cyclic GMP; Estradiol; Humans; Immunohistochemistry; Insecta; Kidney Tubules, Proximal; Methotrexate; Multidrug Resistance-Associated Proteins; Organic Anion Transporters; Rats; Tissue Distribution | 2002 |
Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Antibodies; Carcinoma, Hepatocellular; Cell Polarity; Cholagogues and Choleretics; Cricetinae; Fibroblasts; Gene Expression; Glutathione; Hepatocytes; Humans; Liver Neoplasms; Male; Mice; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Rats; Taurocholic Acid; Transfection; Transport Vesicles; Tritium | 2003 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
InCl
Topics: Animals; Arthritis; Cyclic Nucleotide Phosphodiesterases, Type 4; Encephalomyelitis, Autoimmune, Experimental; Freund's Adjuvant; Indium; Indoles; Molecular Structure; Multiple Sclerosis; Oligodendrocyte-Myelin Glycoprotein; Phosphodiesterase 4 Inhibitors; Quinoxalines; Rats; Structure-Activity Relationship; Zebrafish; Zebrafish Proteins | 2019 |
Growth rate of cultured Novikoff rat hepatoma cells as a function of the rate of thymidine and hypoxanthine transport.
Topics: Adenosine; Animals; Biological Transport; Carcinoma, Hepatocellular; Cell Survival; Cells, Cultured; Dipyridamole; Guanosine; Hypoxanthines; Liver Neoplasms; Methotrexate; Neoplasms, Experimental; Rats; Thymidine; Thymine Nucleotides | 1977 |
Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells.
Topics: Adenocarcinoma; Cell Division; Cell Line; Cell Survival; Colonic Neoplasms; Dipyridamole; DNA Replication; Drug Screening Assays, Antitumor; Drug Synergism; Fluorouracil; Humans; Methotrexate; Pancreatic Neoplasms; Thymidine; Tumor Stem Cell Assay; Zidovudine | 1992 |
Role of hypoxanthine and thymidine in determining methotrexate plus dipyridamole cytotoxicity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cyclic AMP; Dipyridamole; Drug Synergism; Female; Humans; Hypoxanthine; Hypoxanthines; Methotrexate; Ovarian Neoplasms; Thymidine | 1990 |
Dipyridamole-cisplatin potentiation: enhanced in vivo cytotoxicity in xenograft models of human testicular and bladder cancers.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Dipyridamole; Dose-Response Relationship, Drug; Drug Synergism; Humans; Male; Methotrexate; Mice; Mice, Nude; Neoplasm Transplantation; Testicular Neoplasms; Transplantation, Heterologous; Urinary Bladder Neoplasms | 1990 |
Enhancement of methotrexate cytotoxicity towards the MDA.MB.436 human breast cancer cell line by dipyridamole. The role of methotrexate polyglutamates.
Topics: Arachidonic Acid; Arachidonic Acids; Breast Neoplasms; Cell Count; Cell Line; Dipyridamole; Drug Synergism; Female; Humans; Indomethacin; Methotrexate; Polyglutamic Acid; Time Factors | 1986 |
Dipyridamole potentiates the growth-inhibitory action of methotrexate and 5-fluorouracil in human keratinocytes in vitro.
Topics: Cell Division; Dipyridamole; DNA; Drug Synergism; Epidermal Cells; Fluorouracil; Humans; Infant, Newborn; Keratins; Male; Methotrexate; Thymidine | 1989 |
Novel approaches to intraperitoneal drug delivery.
Topics: Antineoplastic Agents; Dipyridamole; Dose-Response Relationship, Drug; Drug Evaluation; Drug Synergism; Etoposide; Female; Humans; Infusion Pumps; Infusions, Parenteral; Long-Term Care; Methotrexate; Ovarian Neoplasms; Peritoneal Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1989 |
5-Fluoropyrimidine-induced DNA damage in human colon adenocarcinoma and its augmentation by the nucleoside transport inhibitor dipyridamole.
Topics: Adenocarcinoma; Colonic Neoplasms; Dipyridamole; DNA; DNA Damage; Floxuridine; Fluorouracil; Humans; Methotrexate; Nucleosides; Tumor Cells, Cultured | 1989 |
[Potentiated antitumor effect of methotrexate by dipyridamole].
Topics: Amphotericin B; Animals; Antineoplastic Agents; Biological Transport; Dipyridamole; Drug Synergism; Female; Leukemia L1210; Male; Methotrexate; Mice; Nucleosides; Sarcoma 180; Tumor Cells, Cultured | 1989 |
The effects of dipyridamole and indomethacin on methotrexate cytotoxicity in LoVo human colon cancer cells.
Topics: Cell Division; Cell Survival; Colonic Neoplasms; Dipyridamole; Humans; Indomethacin; Methotrexate; Tumor Cells, Cultured | 1989 |
Pharmacologic basis for the use of dipyridamole to increase the selectivity of intraperitoneally delivered methotrexate.
Topics: Ascitic Fluid; Cell Line; Dipyridamole; Drug Evaluation, Preclinical; Drug Stability; Drug Synergism; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Methotrexate; Ovarian Neoplasms; Protein Binding; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1989 |
Potentiation of antimetabolite antitumor activity in vivo by dipyridamole and amphotericin B.
Topics: Amphotericin B; Animals; Antimetabolites, Antineoplastic; Dipyridamole; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Lung Neoplasms; Male; Methotrexate; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Sarcoma 180; Uterine Cervical Neoplasms | 1989 |
Selective intraperitoneal biochemical modulation of methotrexate by dipyridamole.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Dipyridamole; Drug Interactions; Female; Fever of Unknown Origin; Humans; Infusions, Parenteral; Male; Methotrexate; Middle Aged; Peritoneal Neoplasms; Peritonitis; Prognosis | 1989 |
Methotrexate and dipyridamole combination chemotherapy based upon inhibition of nucleoside salvage in humans.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dipyridamole; Humans; Methotrexate; Neoplasms; Nucleosides | 1989 |
Potentiation of methotrexate lymphocytotoxicity in vitro by inhibitors of nucleoside transport.
Topics: Cell Survival; Cells, Cultured; Dipyridamole; Drug Synergism; Guanosine; Humans; Lymphocytes; Methotrexate; Thionucleosides | 1989 |
Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamole.
Topics: Cell Line; Cell Survival; Colonic Neoplasms; Dipyridamole; Drug Synergism; Guanine; Humans; Hypoxanthine; Hypoxanthines; Methotrexate; Rectal Neoplasms; Thymidine; Thymine Nucleotides | 1987 |
Phase II trial of oral methotrexate and dipyridamole in colorectal carcinoma.
Topics: Adenocarcinoma; Administration, Oral; Aged; Colonic Neoplasms; Dipyridamole; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Kinetics; Male; Methotrexate; Middle Aged; Rectal Neoplasms | 1987 |
In vitro evaluation of nucleoside transport inhibition in vivo.
Topics: Animals; Biological Transport; Dipyridamole; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Male; Methotrexate; Mice; Mice, Inbred AKR; Mice, Inbred Strains; Nucleosides; Thymidine; Time Factors | 1986 |
S49 mouse lymphoma cells are deficient in hypoxanthine transport.
Topics: Adenine; Animals; Biological Transport; Cell Line; Cricetinae; Cricetulus; Dipyridamole; Hypoxanthine; Hypoxanthine Phosphoribosyltransferase; Hypoxanthines; Lymphoma; Methotrexate; Mice; Permeability; Thymidine; Uridine; Uridine Kinase | 1986 |
Potentiation of methotrexate toxicity by dipyridamole.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cell Survival; Cricetinae; Cricetulus; Dipyridamole; DNA Replication; Drug Synergism; Female; Kinetics; Leukemia L1210; Methotrexate; Mice; Mice, Inbred AKR; Mice, Inbred Strains; Osteosarcoma; Ovary | 1984 |
Dipyridamole inhibits reversion by thymidine of methotrexate effect and increases drug uptake in Sarcoma 180 cells.
Topics: Animals; Biological Transport; Deoxycytidine; Deoxyuridine; Dipyridamole; DNA Replication; Drug Antagonism; Kinetics; Methotrexate; Mice; Sarcoma 180; Thymidine; Thymine Nucleotides | 1984 |
Microcalorimetric evaluation of the effect of combined chemotherapeutic drugs.
Topics: Antineoplastic Agents; Calorimetry; Cell Death; Dipyridamole; Drug Synergism; Humans; Kinetics; Lymphoma, T-Cell; Mercaptopurine; Methotrexate; Thioguanine; Tumor Cells, Cultured | 1995 |
The enhancement of the frequency of resistance to N-phosphonoacetyl-L-aspartate and methotrexate by 1-beta-D-arabinofuranosylcytosine: the effect of dipyridamole.
Topics: Animals; Aspartic Acid; Cell Line, Transformed; Cricetinae; Cytarabine; Dipyridamole; Drug Resistance; Drug Synergism; Humans; Methotrexate; Nucleosides; Phosphonoacetic Acid; Thioinosine | 1994 |
Selective modulation of vinblastine sensitivity by 1,9-dideoxyforskolin and related diterpenes in multidrug resistant tumour cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bucladesine; Colforsin; Cyclic AMP; Dipyridamole; Doxorubicin; Drug Resistance; Humans; Membrane Glycoproteins; Methotrexate; Mice; Neoplasm Proteins; Regression Analysis; Tumor Cells, Cultured; Vinblastine | 1993 |
Mechanism of the discrepant effect of a combination of methotrexate plus dipyridamole on human hematologic cell lines.
Topics: Adult; Cell Division; Child; Dipyridamole; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Infant; Leukemia; Lymphoma; Male; Methotrexate; Middle Aged; Tumor Cells, Cultured | 1993 |
The influence of BIBW22BS, a dipyridamole derivative, on the antiproliferative effects of 5-fluorouracil, methotrexate and gemcitabine in vitro and in human tumour xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Deoxycytidine; Dipyridamole; Doxorubicin; Drug Resistance; Female; Floxuridine; Fluorouracil; Gemcitabine; Humans; Methotrexate; Mice; Mice, Nude; Morpholines; Neoplasms; Neoplasms, Experimental; Protein Binding; Transplantation, Heterologous; Triamterene; Tumor Cells, Cultured; Vincristine | 1995 |
Dipyridamole mediated enhanced antiproliferative activity of 10-ethyl-10-deazaaminopterin (10-EDAM) against human lung cancer cell lines.
Topics: Aminopterin; Biological Transport; Cell Division; Depression, Chemical; Dipyridamole; Dose-Response Relationship, Drug; Drug Synergism; Folic Acid Antagonists; Growth Inhibitors; Humans; Lung Neoplasms; Methotrexate; Nucleosides; Thymidine; Tumor Cells, Cultured | 1996 |
Maintenance of differential methotrexate toxicity between cells expressing drug-resistant and wild-type dihydrofolate reductase activities in the presence of nucleosides through nucleoside transport inhibition.
Topics: 3T3 Cells; Animals; Antimetabolites, Antineoplastic; Carrier Proteins; Dipyridamole; Drug Resistance, Neoplasm; Humans; K562 Cells; Membrane Proteins; Methotrexate; Mice; Nucleoside Transport Proteins; Nucleosides; Phosphodiesterase Inhibitors; Tetrahydrofolate Dehydrogenase | 2000 |
Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells.
Topics: Acetylation; Antimetabolites, Antineoplastic; Azacitidine; Biological Transport; Breast Neoplasms; Carrier Proteins; CpG Islands; Decitabine; Dipyridamole; DNA Methylation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; Folic Acid Antagonists; Gene Silencing; Histone Deacetylases; Histones; Humans; Ion Pumps; Membrane Transport Proteins; Methotrexate; Promoter Regions, Genetic; Reduced Folate Carrier Protein | 2001 |
Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.
Topics: Animals; Antimetabolites, Antineoplastic; Biological Transport; Bone Neoplasms; Cattle; Culture Media; Cytarabine; Dialysis; Dipyridamole; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Fetal Blood; Humans; Hypoxanthine; Methotrexate; Neoplasm Proteins; Nucleotides; Osteosarcoma; Tetrahydrofolate Dehydrogenase; Thymidine; Tumor Cells, Cultured; Vidarabine | 2002 |
Methotrexate modulates the kinetics of adenosine in humans in vivo.
Topics: Adenosine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Dipyridamole; Dose-Response Relationship, Drug; Drug Synergism; Female; Forearm; Hemodynamics; Humans; Male; Methotrexate; Middle Aged; Regional Blood Flow; Severity of Illness Index; Vasodilation; Vasodilator Agents | 2006 |
Methotrexate resistance in vitro is achieved by a dynamic selectionprocess of tumor cell variants emerging during treatment.
Topics: Cell Line, Tumor; Cell Proliferation; Chromosomal Instability; Dipyridamole; Drug Resistance, Neoplasm; Genetic Variation; Humans; Methotrexate; Neoplasms; Nucleosides; Selection, Genetic | 2006 |
A new agent for tumour necrosis factor-alpha inhibition: In vitro effects of dipyridamole in Crohn's disease.
Topics: Adolescent; Adult; Case-Control Studies; Crohn Disease; Dipyridamole; Dose-Response Relationship, Drug; Female; Humans; Interleukin-10; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Methotrexate; Middle Aged; Phytohemagglutinins; Tumor Necrosis Factor-alpha; Young Adult | 2009 |
Effects of extracellular purines on cytotoxicity of methotrexate.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Survival; Culture Media, Conditioned; Deoxyribonucleotides; Dipyridamole; Drug Synergism; Hypoxanthine; Leukemia L1210; Methotrexate; Mice; Purines; Tumor Stem Cell Assay | 2010 |
Sleeping Beauty-Mediated Drug Resistance Gene Transfer in Human Hematopoietic Progenitor Cells.
Topics: Antigens, CD34; Dipyridamole; DNA Transposable Elements; Drug Resistance; Gene Transfer Techniques; Genetic Therapy; Green Fluorescent Proteins; Hematopoietic Stem Cells; Humans; Methotrexate; Tetrahydrofolate Dehydrogenase | 2015 |